Hypotheses on the molecular basis of susceptibility to rheumatoid arthritis.
An interpretive summary of recent immunologic and molecular biologic data concerning the molecular basis of susceptibility of rheumatoid arthritis will be presented. The central point of view is taken that the MHC class II molecules encoding disease susceptibility function in a specific immune recognition event. This could involve an antigen "X" that currently eludes characterization or be directed to polymorphic determinants on the MHC molecule itself. The problem of understanding the meaning of the association of susceptibility to rheumatoid arthritis with diverse MHC alleles such as DR4 (Dw4 and Dw14) and DR1 is approached by detailed biochemical analysis that led to the identification of common stretches of amino acid sequence, presumably encoding conformationally equivalent structures. The sequence shared by the otherwise unrelated DR1 and DR4 haplotypes from residue 67 in the DR a chain that appears to confer susceptibility is Leu-X-X-Gln-Arg/Lys. Non-classic MHC polymorphisms related to disease susceptibility but not associated with particular alleles such as identified by Ab109d6 prove especially valuable in suggesting new directions for attempting to understand the significance of these associations. Consideration is given to the possibility that a family of either slightly different or identical conformations encoded in either cis or trans cumulatively confer the liability to develop rheumatoid arthritis. This implies a highly non-classic mode of inheritance. It seems reasonable to consider the pathogenesis of rheumatoid arthritis as evolving from a typical immune response based on a simple immune recognition event directed to a single antigen.
Winchester
R
R
Hospital for Joint Diseases, New York University Medical Center, New York 10003.
Gregersen
P K
PK
Merryman
P
P
Dwyer
E
E
Lee
S
S
D000943:Antigens, Differentiation / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000235:genetics* / Q000276:immunology; D001483:Base Sequence; D004198:Disease Susceptibility; D000939:Epitopes; D005785:Gene Conversion; D006680:HLA Antigens / Q000276:immunology; D006684:HLA-DR Antigens / Q000235:genetics; D015798:HLA-DR1 Antigen; D015804:HLA-DR4 Antigen; D006801:Humans; D008285:Major Histocompatibility Complex; D008962:Models, Theoretical; D008967:Molecular Biology; D008968:Molecular Conformation
D000943:Antigens, Differentiation; D000939:Epitopes; D006680:HLA Antigens; D006684:HLA-DR Antigens; D015798:HLA-DR1 Antigen; D015804:HLA-DR4 Antigen